Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment. (Q36695952)
Jump to navigation
Jump to search
scientific article published on 2 January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment. |
scientific article published on 2 January 2007 |
Statements
Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment (English)
Severine Loisel
Marc Ohresser
Marc Pallardy
David Daydé
Christian Berthou
Hervé Watier
2 January 2007